CytomX Therapeutics to Participate in Upcoming Healthcare Conferences

NEXT STORY
Revive Therapeutics Enters into Clinical Trial Agreement to Evaluate Psilocybin for the Treatment of Methamphetamine Use Disorder
PREV STORY
BetterLife Pharma Announces Dr. Eleanor Fish to Retain Role as Key Scientific Advisor Following Invitation to Join Government COVID-19 Task Force
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update

author_avatar
NASDAQ Market News

Pluristem’s Pivotal Phase III Critical Limb Ischemia Trial Approved by UK Regulatory Agency

Pluristem expects to begin patient enrollment in the UK in first half of 2017 ...

author_avatar
NASDAQ Market News

Kura Oncology Doses First Patient in Phase 1/2 Clinical Trial of Tipifarnib in Combination with Alpelisib in Head and Neck Squamous Cell Carcinoma

author_avatar
NASDAQ Market News